B

Bergenbio ASA
OSE:BGBIO

Watchlist Manager
Bergenbio ASA
OSE:BGBIO
Watchlist
Price: 11.8 NOK -5.9% Market Closed
Market Cap: 479.2m NOK
Have any thoughts about
Bergenbio ASA?
Write Note

Wall Street
Price Targets

BGBIO Price Targets Summary
Bergenbio ASA

Wall Street analysts forecast BGBIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BGBIO is 20.4 NOK with a low forecast of 5.05 NOK and a high forecast of 39.9 NOK.

Lowest
Price Target
5.05 NOK
57% Downside
Average
Price Target
20.4 NOK
73% Upside
Highest
Price Target
39.9 NOK
238% Upside
Bergenbio ASA Competitors:
Price Targets
UTHR
United Therapeutics Corp
8% Upside
AVTE
Aerovate Therapeutics Inc
11% Downside
ACLX
Arcellx Inc
25% Upside
TNGX
Tango Therapeutics Inc
205% Upside
2616
CStone Pharmaceuticals
26% Upside
ARX
Aroa Biosurgery Ltd
38% Upside
KRYS
Krystal Biotech Inc
8% Upside

Revenue
Forecast

Revenue Estimate
Bergenbio ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-53%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Bergenbio ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Bergenbio ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-69%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BGBIO's stock price target?
Price Target
20.4 NOK

According to Wall Street analysts, the average 1-year price target for BGBIO is 20.4 NOK with a low forecast of 5.05 NOK and a high forecast of 39.9 NOK.

Back to Top